http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-111290-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_648c9679dd9ec36125406a2dafa6bf7e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P60-21 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J13-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05G5-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05G5-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05G5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05G5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05G3-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C05G5-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C05G3-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-28 |
| filingDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fed4b80771be4454aa287be361fa6ca1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_124b4b35378b48424e22cc4458cd3c02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_217d8d343ae4ea74861ef9b84e470d84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9275a695b06fd754ec04282f40130d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faebc10f2b0d851440b01be3917ca440 |
| publicationDate | 2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-111290-A1 |
| titleOfInvention | COMPOSITIONS OF MICROENCAPSULATED NITRIFICATION INHIBITORS |
| abstract | Claim 1: A microcapsule suspension formulation that includes: (a) a first suspended phase of multiple microcapsules having an average particle size in volume of about 1 to about 10 mm, wherein the microcapsules include: (1) a microcapsule wall produced by interfacial polycondensation reaction between a polymeric isocyanate and a polyamine to form a polyurea shell; (2) at least one organic nitrification inhibitor compound encapsulated in the polyurea shell; (b) a second suspended phase of multiple microcapsules having an average particle size in volume of about 1 to about 10 mm, where the microcapsules include: (1) a wall of microcapsules produced by interfacial polycondensation reaction between an isocyanate polymeric and a polyamine to form a second polyurea shell; (2) at least one hydrophobic crystal inhibitor additive encapsulated in the second polyurea shell; and (c) an aqueous phase. Claim 2: The microcapsule suspension formulation according to claim 1, wherein the aqueous phase further includes at least one additional ingredient that is selected from the group consisting; in: dispersants, emulsifiers, rheology assistants, antifoaming agents, biocides, antifreeze agents and mixtures thereof. Claim 3: The microcapsule suspension formulation according to claim 1, wherein the organic nitrification inhibitor compound includes 2-chloro-6- (trichloromethyl) pyridine. Claim 4: The microcapsule suspension formulation according to claim 1, wherein the formulation further includes an active agricultural ingredient that is selected from the group consisting of: arthropodicides, bactericides, fungicides, herbicides, insecticides, miticides, nematicides, fertilizers, dicyandiamide, urease inhibitors and pesticide mixtures thereof. Claim 6: The microcapsule suspension formulation according to claim 1, which further includes at least one ultra-hydrophobic polymeric compound. Claim 7: The microcapsule suspension formulation according to claim 6, wherein the polymer ultra-hydrophobic compound includes polybutene. Claim 9: The microcapsule suspension formulation according to any of claims 1 and 8, wherein the hydrophobic crystal inhibitor additive is at least one compound that is selected from the group that includes aromatic solvents and 2,2,4-trimethyl- 1,3-pentanediol monoisobutyrate. Claim 12: The microcapsule suspension formulation according to claim 11, wherein the emulsifier is a non-ionic polymeric surfactant that is selected from the group consisting of: polyvinyl alcohols. Claim 13: The microcapsule suspension formulation according to claim 2, wherein the dispersant is a modified polymeric styrene acrylic surfactant. Claim 14: The microcapsule suspension formulation according to claim 1, which further includes from about 0 percent by weight to about 5 percent by weight of a non-microencapsulated hydrophobic crystal inhibitor additive. |
| priorityDate | 2017-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.